Although coronary artery bypass grafting (CABG) surgery is a surgical procedure described for coronary artery disease, still unpredicted mortality, and morbidity have been observed \[[@ref1]\]. EuroSCORE is frequently accepted, and used risk assessment model in cardiac surgery \[[@ref2]\]. Because of concerns about under-, or overestimation of the risk, more reliable markers, and scoring systems are needed.

In many studies inflammation markers, and their relationship with cardiovascular risks have been indicated \[[@ref3]\]. White blood cell count (WBC) has been demonstrated as a predictor of mortality after CABG \[[@ref4], [@ref5]\]. However subtypes of WBC, and their ratios have been demonstrated as more valuable predictors than WBC \[[@ref6], [@ref7]\]. Neutrophil/lymphocyte ratio (NLR) can be estimated easily from differential cell counts. Although NLR is a marker of inflammatory conditions, it also enables combined evaluation of neutrophilia, and lymphopenia which have worse cardiovascular prognosis \[[@ref8], [@ref9]\].

We investigated NLR which is an early-phase post-CABG mortality predictor in various age groups.

MATERIALS AND METHODS {#sec1-2}
=====================

After approval of our hospital's scientific publication rating committee, 158 patients who had undergone isolated on-pump CABG operation between 2011, and 2014 by the same surgical team were retrospectively evaluated. The patients were divided into 2 groups as 78 patients of ≤45 years of age (Group 1), and 80 randomly selected patients aged over 45 years (Group 2). Routine biochemical, and hematological values of the patients were recorded. Their pulmonary functions, medications used, presence of diabetes mellitus, and concomitant diseases were investigated, and together with their cardiac data EuroSCORE values were calculated ([Table 1](#T1){ref-type="table"}).

###### 

Preoperative, and operative data

                               Group 1               Group 2               P
  ---------------------------- --------------------- --------------------- -------
  Clinical characteristics                                                 
   N                           78                    80                    NS
   Gender (F/M)                28(35.8%)/50(64.2%)   30(37.5%)/50(62.5%)   NS
   Age (mean)years             39.4±4.1              63.9±9.2              0.001
   EF                          48.7±10.9             48.6±13.1             NS
   Euroscore                   1.2±1.4               3.4±2.3               0.001
   Smoking                     40(51.2%)             33(41.5%)             0.490
   Hypertension                38(48.7%)             35(43.7%)             0.748
   Diabetes mellitus           27(34.7%)             18(22.5%)             0.122
   CVD                         2(2.5%)               4(5%)                 0.317
   Hyperlipidemia              27(34.7%)             20(25%)               0.395
   COPD (Moderate -Advanced)   10(12.8%)             13(16.3%)             0.523
  Laboratory                                                               
   Urea                        23.2±10.7             37.5±12.9             0.001
   Creatinine                  0.9±0.6               2.3±1.3               NS
   WBC                         9.2±2.5               9.7±10.6              NS
   Neutrophil                  5.8±2.1               6.2±5.2               NS
   Lymphocyte                  2.4±0.7               1.9±0.8               0.001
   N/L ratio (mean)            2.47                  4.07                  0.001
  Operatif                                                                 
   Duration of CPB (min)       70.3±44.9             93.6±34.6             0.001
   Duration of CC (min)        52.9±37.6             67.1±26.7             0.007
   CABG (number of grafts)     2.3±0.9               3.0±0.8               0.001
   Mortality (1 month)         2                     11                    0.001

EF: Ejection Fraction; CVD: Cardiovascular Disease; COPD: Chronic Obstructive Pulmonary Disease; WBC: Total White Blood Cell Count; CPB: Cardiopulmonary Bypass; CC: Cross-Clamping; CABG: Coronary Artery Bypass Grafting; NS: Not Significant P\<0.05 significant.

Preoperative demographic characteristics, total white blood cell count, neutrophil ratios, lymphocyte ratios, NLR, cross-clamping, and cardiopulmonary bypass times were recorded ([Table 2](#T2){ref-type="table"}). Primary endpoint was observation of all-cause in-patient mortality. Mean NLR values were calculated separately for each group ([Table 3](#T3){ref-type="table"}).

###### 

Preoperative, and operative data of the patients with decreased, and increased NLR values

               Increased N/L 51   Decreased N/L 107   P
  ------------ ------------------ ------------------- --------
  Age (mean)   50.4±15.2          52.5±13.7           NS
  EF           49.1±10.7          48.4±12.6           NS
  EuroSCORE    2.5±2.5            2.2±2.0             NS
  Urea         31.0±14.9          30.1±13.3           NS
  Creatinine   1.1±0.8            1.9±1.3             NS
  WBC          10.5±3.8           9.0±4.6             NS
  Neutrophil   7.9±3.2            5.1±4.0             0.0001
  Lymphocyte   1.7±0.7            2.4±0.8             0.0001
  CPB          74.7±40.9          85.7±41.6           NS
  CC           52.8±28.9          63.6±34.6           NS
  CABG         2.5±0.9            2.8±0.9             NS
  Mortality    7                  6                   NS

P\<0.05 significant; NS: Not Significant.

###### 

Variables effective on mortality

  Variables               Deceased (13)   Living (145)   P
  ----------------------- --------------- -------------- -------
  Inotropic use           13              77             0.001
  IABP                    6               8              0.001
  Prolonged ventilation   6               11             0.004
  Duration of CPB         104(20-207)     81(0-262)      0.041
  EuroScore               5(3-9)          2(0-9)         0.001
  NLR                     4.28(2-14)      2.33(1-21)     0.001
  Lymphocyte              1.6(1-3)        2.1(0-5)       0.001
  Age (years)             62.6±14         50.8±13.8      0.004

IABP: Intraaortic Balloon Pump; CPB: Cardiopulmonary Bypass;

NLR: Neutrophil/Lymphocyte Ratio.

Statistical analysis {#sec2-1}
--------------------

The patients included in the study were analyzed in two separate groups, and 4 subgroups, and values were expressed as mean±standard deviation. Parametric data were evaluated with t-test, and non-parametric data using chi-square test. In the evaluation of characteristics effective on mortality, Pearson's two-way correlation test was used. P\<0.05 was accepted as statistically significant.

RESULTS {#sec1-3}
=======

Estimated threshold NLR values were 2.47 for Group 1, and 4.07 for Group 2. In Group 1, a significant correlation was not detected between mortality rates, and NLR values in patients whose NLR values were above threshold values (p\<0.05). In Group 2, a significant correlation was detected between mortality rates, and NLR values in patients whose NLR values were above threshold values (p\<0.01). When all patients included in the study were evaluated, a significant correlation was not found between NLR values, and mortality rates (p\<0.05). In addition, a statistically significant correlation existed between EuroSCORE scale scores, and mortality rates. Higher mortality rates were detected in patients with higher EuroSCORE scale scores (p=0.0001). However any relation of this association with NLR values was not observed. (p\>0.05). Only in the group with higher EuroSCORE scale scores left ventricular ejection fraction (EF) was effective on mortality (p=0.0001). However age, NLR, and even lower EF values had no effect on mortality rates ([Table 2](#T2){ref-type="table"}). Difference detected between creatinine levels of both two group were not statistically significant. This difference in creatinine levels might trigger inflammatory processes with resultant higher NLR values. However as stated above this difference was not statistically significant.

Exclusion criteria {#sec2-2}
------------------

Patients who underwent off-pump surgery, concurrent valvular surgery, urgently operated cases, those with acute or chronic infections, known malignancies, and hematological problems were not included in the study.

DISCUSSION {#sec1-4}
==========

The main purpose of developing EuroSCORE system was to measure the quality of cardiac surgical procedures \[[@ref10]\]. However following its introduction into medical practice, inadequacities of the EuroSCORE system have been reported \[[@ref11]\]. Later on, another scoring system by The Society of Thoracic Surgeons (STS) was described, and published \[[@ref12]\]. STS scoring system which is more detailed relative to the EuroSCORE system has demonstrated its superiority over EuroSCORE in many cardiac surgery groups \[[@ref13]-[@ref15]\]. However clinical application of STS scoring system is very difficult. Therefore, in our clinic we are using EuroSCORE system for risk assessments. In our survey, we have detected higher EuroSCORE values in patients with increased risk of mortality. However higher mortality rates have been evaluated independent from increases in NLRs.

The primary purpose of using risk scoring systems, and biopredictors is to predict unwanted intraoperative conditions. In addition to EuroSCORE systems, new markers have been defined. Total white blood cell count was the first biopredictor found to be correlated with mortality. Bagger et al. performed a study on 2058 patients, and determined WBC as a predictor of post-CABG 30-day mortality \[[@ref4]\]. Besides, Newall et al. in their series consisting of 3024 patients, detected a correlation between preoperative WBC, and perioperative myocardial injury, and 1-year mortality \[[@ref5]\]. Despite the outcomes of such a large series, it is known that white blood cell count is a nonspecific marker which can increase due to various conditions. For this reason, it is not reliable to use this marker by itself. Contrary to these studies, Gibson et al. analyzed specific cell counts, and ratios in a study population of 1938 patients, and couldn't find a correlation between WBC, and mortality rates \[[@ref8]\].

Recently, NLR has become prominent as a biomarker. As an indicator of inflammatory state, combination of netrophilia, and lymphopenia has been associated with poor cardiovascular prognosis \[[@ref16]\]. Increase in the number of neutrophils is an indicator of active inflammatory process, while decrease in the number of lymphocytes is an indicator of inadequacy of the active inflammatory process. Correlation between lymphopenia, and progression of atherosclerosis, and major cardiac complications has been demonstrated \[[@ref17],[@ref18]\]. Neutrophils induce formation of reactive oxygen radicals, and inflammatory mediators in myocardium during CPB \[[@ref19]\]. In large series, it is possible to correlate preoperative NLR, and post-CABG mortality rates. Gibson et al. pioneered this assumption. A correlation between preoperative NLR derived from WBC and mortality rates exists which is independent from well-known personal factors, and EuroSCORE values \[[@ref8]\]. In a study performed by Ünal et al., a correlation was detected between preoperative NLR, and post-CABG mortality rates \[[@ref20]\]. However in our study among young patient group an association between NLR, and mortality was not detected, however a correlation was found between NLR, and mortality in the elder patient group. When all patients were considered, a correlation was not detected between NLR, and mortality rates.

Limitations of the study: A single-centered investigation was performed on a small patient group which can be considered as an important limitation of our study. Apart from many clinical parametres we evaluated, unknown factors as inflammatory responses induced by cardiac injury during clinical course, and cardiopulmonary bypass might effect accuracy of our outcomes.

CONCLUSION {#sec1-5}
==========

We think that, as an easily calculable post-CABG biopredictor of mortality with low cost, NLR together with EuroSCORE scoring system can be used in the elder population. In our study, higher NLO value has been demonstrated as a marker of mortality. However for quantitative determination of the risk of mortality based on NLR values, larger-scale studies should be conducted.
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